Why the study?
Does low-density lipoprotein modulate collagen metabolism in cultured human skin fibroblasts?
Does low-density lipoprotein modulate collagen metabolism in cultured human skin fibroblasts?
LDL increases matrix metalloproteinase-1 and collagen I mRNA in fibroblasts, suggesting a regulatory role in collagen metabolism and a potential mechanism for tissue remodeling in atherosclerosis.
Answers are grounded in this paper and cite their sources.
LDL may drive fibroblast matrix remodeling in vitro; leaves open heparin's role in atherosclerosis and requires in vivo confirmation.
High levels of low-density lipoprotein are associated with atherosclerosis, and myocardial and arterial remodeling. We postulated that low-density lipoprotein influences collagen synthesis and degradation in fibroblasts as a potential mechanism of tissue remodeling. Incubation of cultured human skin fibroblasts with low-density lipoproteins resulted in a time-dependent and dose-dependent increase in the secretion of matrix metalloproteinase activity measured by gelatin zymography. Western blot analysis showed a concomitant increase in matrix metalloproteinase-1 protein. Northern blot analysis demonstrated an increase in collagen I messenger RNA after treatment with low-density lipoprotein. The matrix metalloproteinase-1 secretory response of fibroblasts to low-density lipoprotein was attenuated by heparin, which inhibits low-density lipoprotein uptake through the low-density lipoprotein-receptor. These observations suggest that low-density lipoprotein has a regulatory effect on collagen metabolism in fibroblasts.
No takes yet. Share an insight, caveat, or question.
Joseph et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: